Transversus Thoracic Plane Block for Perioperative Analgesia in Cardiac Surgery

August 7, 2024 updated by: Joanna Tohme, Saint-Joseph University

Transversus Thoracic Plane Block for Perioperative Analgesia in Cardiac Surgery: a Randomized Controlled Prospective Study

The goal of this clinical trial is to learn if perioperative Transversus Thoracic Plane Block (TTPB) decrease perioperative pain after cardiac surgery. The main questions it aims to answer are:

  1. does Transversus Thoracic Plane Block decrease perioperative pain after cardiac surgery more than the standard analgesic treatment?
  2. Are the results different if the investigators perform Transversus Thoracic Plane Block before surgery or at the end of surgery?

Study Overview

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Beirut, Lebanon, 166830
        • Hotel Dieu de France

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- All patients scheduled for cardiac surgery via sternotomy under cardiopulmonary bypass

Exclusion Criteria:

  • Previous cardiac surgery
  • Urgent surgery
  • Pregnant women
  • Allergy to local anesthetics
  • Opioid dependence
  • Low ejection fraction < 30%
  • Presence or onset of cognitive or neurological disorders preventing pain assessment
  • Infection at injection sites
  • Coagulopathy
  • Patients on dual antiplatelet therapy
  • Renal insufficiency with Glomerular filtration rate (GFR) < 30 mL/min
  • History of thoracic radiotherapy
  • History of mastectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Placebo
This group receives standard analgesic treatment and no Transversus Thoracic Plane Block is performed
Active Comparator: Transversus Thoracic Plane Block pre
This group receives standard analgesic treatment and Transversus Thoracic Plane Block is performed before surgery
The Transversus Thoracic Plane Block is a recent regional anesthesia technique. It provides analgesia for the anterior cutaneous branches of the intercostal nerves T2-6 to the medial anterior chest wall via a single injection of local anesthesia between the internal intercostal muscle and the transversus thoracic muscle located between the third and fourth (or fourth and fifth) intercostal space. It is noteworthy that the TTPB can consequently reduce pulmonary morbidity and the need for high-dose opioids.
Active Comparator: Transversus Thoracic Plane Block post
This group receives standard analgesic treatment and Transversus Thoracic Plane Block is performed at the end of surgery
The Transversus Thoracic Plane Block is a recent regional anesthesia technique. It provides analgesia for the anterior cutaneous branches of the intercostal nerves T2-6 to the medial anterior chest wall via a single injection of local anesthesia between the internal intercostal muscle and the transversus thoracic muscle located between the third and fourth (or fourth and fifth) intercostal space. It is noteworthy that the TTPB can consequently reduce pulmonary morbidity and the need for high-dose opioids.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative pain score
Time Frame: First 24h postoperatively

The primary outcome is Postoperative Pain Score:

Numeric rating scale (NRS) ratings will be assessed at T1 (= upon patient awakening), T2 (= 12 hours postoperatively), T3 (= 24 hours postoperatively) as well as during various painful moments (coughing, drain removal, mobilization).

Numeric rating scale (NRS) is a unidimensional measure of pain intensity. It consists of the patient evaluating his pain out of a series of numbers ranging from 0 to 10, where the 2 respective endpoints are "0 = no pain" and "10 = worst possible pain."

First 24h postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative opioid requirement
Time Frame: First 24h postoperatively
Total dose of opioids required during surgery and 24h postoperatively
First 24h postoperatively
Time to first opioid administration
Time Frame: First 24h postoperatively
Time to first opioid administration after surgery
First 24h postoperatively
Time to extubation
Time Frame: First 24h postoperatively
Time between arrival to cardiac intensive care unit and extubation
First 24h postoperatively
Patient satisfaction at 24 hours post surgery
Time Frame: First 24h postoperatively

Patient satisfaction is measured by asking patients one question at 24 hours post surgery:

"On a scale from 0 to 10, 0 = not satisfied at all, 10 = extremely satisfied, how satisfied do you feel concerning pain management during the first 24 hours after surgery? "

First 24h postoperatively
Length of stay at cardiac intensive care unit and hospital stay
Time Frame: 3 months postoperatively
Length of stay at cardiac intensive care unit and hospital stay
3 months postoperatively
Incidence of postoperative pneumonia and pneumothorax in cardiac intensive care unit
Time Frame: First 24h postoperatively
Incidence of postoperative pneumonia and pneumothorax in cardiac intensive care unit
First 24h postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Samia Madi Jebara, MD,PHD, Saint-Joseph University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

August 4, 2024

First Submitted That Met QC Criteria

August 7, 2024

First Posted (Actual)

August 9, 2024

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 7, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CEHDF2392

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Surgery

Clinical Trials on Transversus Thoracic Plane Block

Subscribe